![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 217/26 | (2006.01) |
A61K 31/47 | (2006.01) | ||
A61P 13/12 | (2006.01) |
(11) | Number of the document | 3679017 |
(13) | Kind of document | T |
(96) | European patent application number | 18742967.5 |
Date of filing the European patent application | 2018-07-11 | |
(97) | Date of publication of the European application | 2020-07-15 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2018/068754 |
Date | 2018-07-11 |
(87) | Number | WO 2019/042641 |
Date | 2019-03-07 |
(30) | Number | Date | Country code |
17189195 | 2017-09-04 | EP | |
18165661 | 2018-04-04 | EP |
(72) |
LENGAUER, Hannes , AT
PICHLER, Arthur , AT
MARGREITER, Renate , AT
GELBRICH, Thomas , AT
|
(73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |
CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |